Researchers at the University of Pennsylvania have identified a protein that may play a central role in how Parkinson’s disease spreads through the brain. Their findings suggest that blocking this ...

Seven months after Novo Nordisk abandoned its push into cell therapy, the pharma’s Parkinson’s disease program looks like ...

Patients suffering from Parkinson's disease may soon benefit from a powerful treatment option: stem-cell transplants. In a pair of small studies designed primarily to test safety, two teams of ...

Monoclonal antibodies can block a key immune‑related protein that drives the spread of brain cell damage in Parkinson's ...

The approval of Sumitomo Pharma's Amchepry makes it the world's first commercialized medical product derived from iPS cells.

'This cell therapy Parkinson's program is truly innovative and exemplifies the powerful convergence of exciting academic ...

The deal gives Cellular Intelligence control of a clinical-stage therapy designed to restore the dopamine-producing nerve ...

LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have found a potential new target for treating Parkinson's disease. Their new research reveals how a protein in brain cells may drive ...

A rare and fatal brain disorder with no available treatment or cure. One that attacks the nervous system, balance, and the ability to move.